Dr. Giuseppe Curigliano is Director of the Division of New Drugs Development for Innovative Therapies at the European Institute of Oncology and is responsible for the Department of Medical Hospitalization for solid tumors. His staff includes four doctors, two of them structured, and two freelance consultants. The Division activities take place in the Departments of Hospitalization, Day Hospital and Clinic and are complemented by the activity of two research nurses and two data managers. He is a member of the Advisory Board of the clinical and research program on Breast Cancer and the program on Urogenital Cancer. In 2013, the Division completed 1393 outpatient services and 1500 Day Hospital activities in the context of clinical trials with innovative treatments and experimental therapies (mainly in breast cancer). The Division has provided 600 services for patients admitted in the medical area.